Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
about
Genistein effects on stromal cells determines epithelial proliferation in endometrial co-culturesEpicatechin stimulates mitochondrial activity and selectively sensitizes cancer cells to radiationIsoflavones are safe compounds for therapeutical applications - evaluation of in vitro data.Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancerThe effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumorChemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal modelsPhytochemicals in cancer prevention and therapy: truth or dare?Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injuryIn vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatmentGenistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells.Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cellsBack to basics: how natural products can provide the basis for new therapeutics.Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.Perspectives on the role of isoflavones in prostate cancer.Role of phytoestrogens in cancer therapy.Radioprotection of lung tissue by soy isoflavonesDifferential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.Soy isoflavones in conjunction with radiation therapy in patients with prostate cancerSoy isoflavones and prostate cancer: a review of molecular mechanisms.Risks and benefits of dietary isoflavones for cancer.Molecular targets for radiation oncology in prostate cancer.The use of antioxidants in radiotherapy-induced skin toxicity.Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.Aneugenic effects of the genistein glycosidic derivative substituted at C7 with the unsaturated disaccharide.Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.Synthetic genistein glycosides inhibiting EGFR phosphorylation enhance the effect of radiation in HCT 116 colon cancer cells.Potential Contributions of Antioxidants to Cancer Therapy.In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol.The prospective role of plant products in radiotherapy of cancer: a current overview.Soy isoflavones ameliorate the adverse effects of chemotherapy in children.Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells
P2860
Q28388428-D0F24363-514D-4DD0-B488-008B6CE3E93BQ28539640-FA98AEC2-7A1E-42D7-9C4C-37FF01C667BCQ33480555-B35E6BC3-1742-4259-81C8-3E00A70C528AQ33908395-66181322-F97B-4EB0-BAE9-E08B4F295FA1Q34187693-1FFF01ED-4B79-49B2-9A48-251F014D437DQ34754097-B651ACB6-E81F-445D-8FDC-B5C89FE85C30Q35014332-24CF6F30-3887-4A35-8B6A-B230EE52EF96Q35155749-51C8E5D7-8B4B-410C-B814-F4126EC6DD68Q35588229-2D664040-6E3D-43FA-8BBC-813ABCC5FC7BQ35722741-0E9FF740-B23E-459C-93C5-411A1D464F1EQ35844645-BEA03C1D-00D8-491F-9717-8F9585617725Q36196702-777DE2FD-EBBC-4C15-963C-8FC57D287C79Q36924212-F0604007-89A8-4882-82C6-BFEE39933D3DQ36985862-A3250A4B-BF31-4715-90FC-294CF2D0D8EAQ37161829-872062D3-C744-433A-A831-E9F0B79CEAC7Q37207772-14DED343-8613-4D07-A507-351DE38FE2ABQ37238391-82AB1046-C8A0-4798-9232-5CE27F989C55Q37238814-3EDB8653-5750-4706-A215-B1DE3200D42EQ37341807-9993C15E-9C08-4B1C-8877-74545A4931BDQ37376217-3776443D-FB36-412C-B391-85213EFDF56CQ37654590-A298098A-EA3F-440B-87C2-114E99919201Q37857841-40442226-5FF8-4468-A8F0-0AB487D495E3Q38014447-3F4E81AE-63C5-4502-9FF1-35F39B539FA6Q38111318-1DE6C905-ED89-4596-9BE8-04193B8E2FB1Q38180344-C0176087-8454-4238-BFD4-2DB1D8718EBDQ38323103-E9EA9332-DE03-40FB-8EB2-0C085AA88C6EQ38566898-CCB638EC-497D-4A25-BF57-2AE5693B7FB2Q38940074-3C0239D1-84BC-4C54-B1C7-700159FBB654Q39382149-045D65E0-C26D-43BA-8523-626EF8A2C681Q39961766-67B17D99-F51F-4C11-8732-175022D9222DQ40239123-B32DBD72-5409-40B3-8C80-9F6D8CDD1EAEQ42868805-6F336E05-FBA1-4610-8CB9-B3F2D9695909Q58605654-D7D80D36-AC2A-44D4-A05C-A835AFA1F6F0
P2860
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
@en
type
label
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
@en
prefLabel
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
@en
P2093
P356
P1476
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
@en
P2093
Daniel R Doerge
Gilda G Hillman
Judith Abrams
Julian J Raffoul
Mingxin Che
Omer Kucuk
Sanjeev Banerjee
Zvi E Knoll
P304
P356
10.1002/IJC.22548
P577
2007-06-01T00:00:00Z